I-Corps: Novel applicator for Magnetic Resonance Imaging

该I-Corps项目的更广泛影响/商业潜力是改善患者护理，减少患者不适和感染，减少用户不适，并由于早期检测而降低给定人群中的疾病流行率。 采用这一技术将对行政和财务业务目标产生更广泛的影响。此外，使用该技术将减少诊断成像中使用的资源，并有助于减少骨盆MRI程序的准备时间，这一点不能过分强调。通过增加额外MR检查的可用成像插槽，减少的时间转化为增加的吞吐量，并导致更高的收入捕获。这个I-Corps项目将探索一种新技术的商业潜力，以提供积极的对比。 这将是对诊断成像领域的有益介绍。该设备将能够提高分期检查的诊断能力（提高灵敏度和准确性），以检测原发性和/或转移性盆腔肿瘤。 该项目将使人们更好地了解当前的实践，并了解如何将该产品纳入以增强临床操作。该奖项反映了NSF的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。

The broader impact/commercial potential of this I-Corps project is to improve patient care, decrease patient discomfort and infection, decrease user discomfort, and decrease prevalence of disease within a given population due to early detection. Adoption of this technology would provide broader implications for both administrative and financial operational goals. Further, using this technology would reduce resources used within diagnostic imaging and help reduce preparation time for pelvic MRI procedures and this cannot be over emphasized. Decreased time translates to increased throughput by increasing available imaging slots for additional MR examinations and leading to higher revenue capture. This I-Corps project will explore the commercial potential for a novel technology to deliver positive contrast. This would be a beneficial introduction to the field of diagnostic imaging. The device would be able to increase the diagnostic ability of staging examinations (increased sensitivity and accuracy) for detection of primary and/or metastatic pelvic tumors. This project will lead to a better understanding of current practices and see how this product can be incorporated to enhance clinical operations.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.